|
XRCC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.645750E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.808450E-04 |
| Normal-vs-Stage2 |
3.635800E-02 |
| Normal-vs-Stage3 |
2.759800E-03 |
| Normal-vs-Stage4 |
2.817000E-04 |
| Stage1-vs-Stage2 |
6.742000E-01 |
| Stage1-vs-Stage3 |
7.894600E-01 |
| Stage1-vs-Stage4 |
1.460820E-01 |
| Stage2-vs-Stage3 |
5.493600E-01 |
| Stage2-vs-Stage4 |
2.180600E-01 |
| Stage3-vs-Stage4 |
4.374400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.409280E-04 |
| Normal-vs-AfricanAmerican |
2.883800E-03 |
| Normal-vs-Asian |
1.343550E-03 |
| Caucasian-vs-AfricanAmerican |
8.146600E-01 |
| Caucasian-vs-Asian |
2.336000E-01 |
| AfricanAmerican-vs-Asian |
1.372350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14719999999113E-05 |
| Normal-vs-Female |
1.058560E-01 |
| Male-vs-Female |
3.705900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.376500E-03 |
| Normal-vs-Extreme_Weight |
8.12140000000516E-05 |
| Normal-vs-Obese |
1.167830E-02 |
| Normal-vs-Extreme_Obese |
9.641900E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.319000E-01 |
| Normal_Weight-vs-Obese |
4.513400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.966400E-01 |
| Extreme_Weight-vs-Obese |
8.776100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.823400E-01 |
| Obese-vs-Extreme_Obese |
1.560840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.855000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.789700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.995060E-04 |
| Normal-vs-Age(81-100Yrs) |
3.784400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.381800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.023600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.287800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.103600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.753960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.834560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.399300E-03 |
| Normal-VS-Type2 PRCC |
1.67215999999915E-05 |
| Normal-VS-KIRP CIMP |
8.604000E-01 |
| Normal-VS-Unclassified PRCC |
1.003630E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.294300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.354250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.175800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.902500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.545800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.204300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27760000000021E-05 |
| Normal-vs-N1 |
3.090500E-02 |
| Normal-vs-N2 |
9.188100E-02 |
| N0-vs-N1 |
2.202800E-01 |
| N0-vs-N2 |
6.825400E-01 |
| N1-vs-N2 |
8.572200E-01 |
|
|
